Skip to Main Content

Baxter International Inc.

BAX Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of BAX by members of U.S. Congress

Politician Type Traded
Ro Khanna House / D Sale $1,001 - $15,000 Nov 10, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Oct 31, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Oct 30, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Oct 30, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 29, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Sep 25, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Sep 05, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Sep 05, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Sep 03, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 26, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 26, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Aug 12, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Aug 12, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Aug 04, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Jul 22, 2025
Ro Khanna House / D Sale $15,001 - $50,000 Jun 26, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jun 23, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jun 16, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jun 16, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jun 10, 2025
Robert Bresnahan House / R Purchase $1,001 - $15,000 May 15, 2025
Ro Khanna House / D Sale $1,001 - $15,000 May 08, 2025
Ro Khanna House / D Sale $1,001 - $15,000 May 08, 2025
Ro Khanna House / D Sale $1,001 - $15,000 May 06, 2025
Ro Khanna House / D Sale $1,001 - $15,000 May 06, 2025
Ro Khanna House / D Sale $1,001 - $15,000 May 06, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 23, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 09, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 09, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 09, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 08, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 08, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 03, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 03, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 03, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Mar 10, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Mar 10, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Mar 07, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Mar 07, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 06, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jan 17, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 17, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Debbie Wasserman Schultz House / D Purchase $1,001 - $15,000 Nov 18, 2024
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
BAX Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
BAX Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
BAX Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in BAX holdings by institutional investors

Quarterly net insider trading by BAX's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $30,000 Jan 06, 2022 Issue: Medicare/Medicaid Health Issues
  • $30,000 Oct 13, 2021 Issue: Health Issues Medicare/Medicaid
  • $30,000 Jul 12, 2021 Issue: Health Issues Medicare/Medicaid
  • $30,000 Apr 08, 2021 Issue: Health Issues Medicare/Medicaid
  • $30,000 Jan 07, 2021 Issue: Medicare/Medicaid Health Issues

BAX Estimated quarterly lobbying spending

BAX Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
BAX Income Statement
BAX Balance Sheet
BAX Cash Flow
U.S. Patents

New BAX patent grants

  • Patent Title: Cable retainer Dec. 02, 2025
  • Patent Title: Display screen with a virtual pharmacy tutorial graphical user interface Jul. 01, 2025
  • Patent Title: Infusion pump Nov. 19, 2024
  • Patent Title: Monitor outlet Sep. 17, 2024
  • Patent Title: Infusion pump with rechargeable battery Dec. 12, 2023
  • Patent Title: Infusion pump rack Jun. 13, 2023
  • Patent Title: Syringe pump Jun. 13, 2023
  • Patent Title: Sensor patch Jun. 06, 2023
  • Patent Title: Infusion pump with rechargeable battery Sep. 27, 2022
  • Patent Title: Connector for sensor Sep. 13, 2022
  • Patent Title: Sensor May. 24, 2022
  • Patent Title: Monitor connector Jul. 06, 2021
  • Patent Title: Dual chamber flexible container Oct. 27, 2020
  • Patent Title: Portable electronic display with animated gui Sep. 29, 2020
  • Patent Title: Portable electronic display with animated gui Sep. 22, 2020
  • Patent Title: Portable electronic display with animated gui Sep. 22, 2020
  • Patent Title: Portable electronic display with animated gui Sep. 15, 2020
  • Patent Title: Portable electronic display with animated gui Sep. 08, 2020
  • Patent Title: Portable electronic display with animated gui Sep. 08, 2020
  • Patent Title: Portable electronic display with animated gui Sep. 01, 2020
  • Patent Title: Inline pressure sensor and electrical connector Feb. 18, 2020
  • Patent Title: Inline pressure sensor and electrical connector Feb. 18, 2020
  • Patent Title: Inline pressure sensor and electrical connector Oct. 22, 2019
  • Patent Title: Antimicrobial housing and cover for a medical device Jun. 25, 2019
  • Patent Title: Method for the improvement of mesh implant biocompatibility Jun. 12, 2018
  • Patent Title: System and method to efficiently clean a blood filter May. 15, 2018
  • Patent Title: Blood treatment and electrical blood leak detection device therefore Apr. 24, 2018
  • Patent Title: Drain and fill logic for automated peritoneal dialysis Apr. 17, 2018
  • Patent Title: Total chlorine water detection system for medical fluid treatments Apr. 17, 2018
  • Patent Title: Method of operating an infusion pump with a multiple orientation display Apr. 10, 2018
  • Patent Title: Integrated water testing methods for ultra-low total chlorine detection Apr. 10, 2018
  • Patent Title: Systems and methods for intelligent patient interface device Apr. 03, 2018
  • Patent Title: Dialysis machine having auto-connection system with roller occluder Apr. 03, 2018
  • Patent Title: Multi-state alarm system for a medical pump Mar. 27, 2018
  • Patent Title: Renal therapy machine and system including a priming sequence Mar. 27, 2018
  • Patent Title: Non-invasive radio frequency medical fluid level and volume detection system and method Mar. 06, 2018
  • Patent Title: Immobilization of an active agent on a substrate Feb. 20, 2018
  • Patent Title: Dialysis system including automatic priming Feb. 13, 2018
  • Patent Title: Hemodialysis system with cassette-based blood and dialysate pumping Feb. 06, 2018
  • Patent Title: Renal therapy system having pump reversing fluid control Jan. 23, 2018
  • Patent Title: Hemostatic sponge Jan. 23, 2018
  • Patent Title: Optimization of nucleation and crystallization for lyophilization using gap freezing Jan. 16, 2018
  • Patent Title: Catheter/fistula needle to bloodline connection assurance device Jan. 16, 2018
  • Patent Title: Battery management system Jan. 02, 2018
  • Patent Title: Dialysis system including heparin injection Jan. 02, 2018
  • Patent Title: Hemostatic compositions Dec. 05, 2017
  • Patent Title: Non-invasive radio frequency liquid level and volume detection system and method using phase shift Nov. 28, 2017
  • Patent Title: Percutaneous administration device and method for injecting medicinal substances Nov. 28, 2017
  • Patent Title: Handle for pump Mar. 04, 2014
  • Patent Title: Needleless connector Jan. 24, 2012
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to BAX from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
BAX News

Recent insights relating to BAX

CNBC Recommendations

Recent picks made for BAX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in BAX

BAX Analyst Ratings

BAX Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
BAX Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $BAX stock a Buy, Sell, or Hold?

  • What is the price target for $BAX stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

BAX Top Shareholders
Shareholder
Shares Held
BAX Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $BAX stock?

  • Who owns the most shares of $BAX stock?

  • What funds own $BAX stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

BAX Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view BAX Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About BAX

Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

  • Address Deerfield, IL
  • Market Cap 9.7 billion
  • Employees 38,000
  • Industrial Classification Surgical & Medical Instruments & Apparatus
Back To Top